作为自身免疫性脑炎的二线治疗方法,利图西马布的有效性:系统性审查和元分析
Lin-Ming Zhang1, Xuan-Lin Xing2, Bing-Ran Zhang2
1Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
Heliyon
|January 30, 2025
概括
利图西马布为自身免疫性脑炎 (AE) 患者提供了80%的良好预后,这些患者对初始治疗没有反应. 这种疗法在年轻的患者和早期被诊断的患者中更有效,改善了难以治疗的AE病例的结果.
科学领域:
- 神经免疫学 神经免疫学
- 药理学 药理学是指药理学的学科.
- 临床神经学 临床神经学
背景情况:
- 自身免疫性脑炎 (AE) 往往对一线治疗反应不佳,需要替代治疗.
- 利图西马布是AE的潜在二线干预措施,但证据需要系统评估.
- 持续的神经缺陷强调了需要在AE有效的救援疗法.
研究的目的:
- 系统地评估和元分析利图西马布作为AE的二线治疗的疗效.
- 为了确定AE患者的最佳治疗策略,AE患者对初始治疗的反应不足.
- 巩固现有证据,以利图西马布在耐火性AE的有效性.
主要方法:
- 在PubMed,Embase和Cochrane图书馆进行了全面的文献搜索,截至2024年6月10日.
- 数据提取和选由两位研究人员独立进行.
- 使用R4.2.1软件进行统计分析,将包含的研究结果汇总在一起.
主要成果:
- 分析包括14项研究,包括277例AE病例.
- 利图西马布的整体预后率为80% (95% CI:0.72-0.89).
- 在18岁以下的患者 (85%) 与成年人 (72%) 相比,疗效更高,在疾病持续时间≤180天 (82%) 与更长时间 (74%) 的病例中,疗效更高.
结论:
- 利图西马布是一种有效的二线治疗自身免疫性脑炎,达到80%的良好预后.
- 较年轻的患者 (18岁以下) 和疾病持续时间较短的患者 (≤180天) 显示Rituximab的优异结果.
- 这些发现支持Rituximab作为耐火AE的有价值的治疗选择.
更多相关视频
08:38Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
Published on: April 9, 2012
20.2K
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
7.6K
相关概念视频
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...